Upgrade to SI Premium - Free Trial

Verrica Pharmaceuticals Inc. (VRCA)

5.30 -0.06 (1.12%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Verrica completes enrollment in YCANTH wart trial, data due Q1 2027 August 27, 2026 8:00 AM - StreetInsider Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027 August 27, 2026 8:00 AM - StreetInsider Lake Street Starts Verrica Pharmaceuticals (VRCA) at Buy August 27, 2026 7:56 AM - StreetInsider Form 4 Verrica Pharmaceuticals For: Aug 17 Filed by: Zawitz David August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 14 Filed by: Rieger Jayson August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 17 Filed by: Rosenberg Noah L. August 18, 2026 5:00 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Aug 18 Filed by: Kirby John J. August 18, 2026 5:00 PM - SEC Filing Verrica Pharmaceuticals Inc. (VRCA) Misses Q2 EPS by 8c August 6, 2026 4:46 PM - StreetInsider Form 10-Q Verrica Pharmaceuticals For: Jun 30 August 6, 2026 4:43 PM - SEC Filing Form 8-K Verrica Pharmaceuticals For: Aug 06 August 6, 2026 4:40 PM - SEC Filing Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results August 6, 2026 4:05 PM - StreetInsider Verrica Pharmaceuticals closes $27.5M credit facility with chairman August 6, 2026 4:01 PM - StreetInsider Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital  August 6, 2026 4:01 PM - StreetInsider Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 July 30, 2026 8:00 AM - StreetInsider Verrica Pharma signs Israel deal for skin disease treatment YCANTH July 21, 2026 8:00 AM - StreetInsider Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel July 21, 2026 8:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Verrica Pharmaceuticals (VRCA) June 23, 2026 6:53 AM - StreetInsider Verrica doses first U.S. patient in COVE-3 trial for common warts June 22, 2026 8:05 AM - StreetInsider Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts  June 22, 2026 8:05 AM - StreetInsider Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Nguyen Diem June 9, 2026 4:16 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Eichenfield Lawrence June 9, 2026 4:16 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: PRYGOCKI MARK A SR June 9, 2026 4:16 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Rosenberg Noah L. June 9, 2026 4:16 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Rieger Jayson June 9, 2026 4:15 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Zawitz David June 9, 2026 4:15 PM - SEC Filing Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Corcoran Gavin June 9, 2026 4:15 PM - SEC Filing Form 8-K Verrica Pharmaceuticals For: Jun 05 June 9, 2026 4:06 PM - SEC Filing Full Article List